Dr Reddys Laboratories (RDY) Shares Outstanding (Weighted Average) (2012 - 2026)

Dr Reddys Laboratories' Shares Outstanding (Weighted Average) history runs 15 years deep, the most recent figure standing at $9.1 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 5.04% year-over-year to $9.1 million; the TTM figure through Mar 2026 stood at $9.1 million (down 5.04% YoY), while the FY2026 annual figure was $9.0 million, down 10.0% from the prior year.
• Shares Outstanding (Weighted Average) was $9.1 million for Q1 2026 at Dr Reddys Laboratories, up from $548335.2 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $9573.1 billion in Q3 2025 to a low of $199107.5 in Q2 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $563.1 billion across 5 years, with a median of $1.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) sank 81.9% in 2024, then surged 2522187567.91% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.6 million in 2022, then tumbled by 76.36% to $615267.0 in 2023, then declined by 6.16% to $577380.0 in 2024, then decreased by 5.03% to $548335.2 in 2025, then soared by 1565.81% to $9.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $9.1 million (Q1 2026), $548335.2 (Q4 2025), and $9573.1 billion (Q3 2025), per Business Quant data.